Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin

Annals of Pharmacotherapy

Volumn 50, Issue 4, 2016, Pages 270-275

  Ricket, Abby L ^a   Stewart, David W ^b   Wood, Robert C ^b,c   Cornett, Lyndsey ^b   Odle, Brian ^b   Cluck, David ^b   Freshour, Jessica ^b   El Bazouni, Hadi ^b  

^a MANCHESTER UNIVERSITY   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

^c James H Quillen VA Medical Center   (United States)

Author keywords

deep vein thrombosis; enoxaparin; pulmonary embolism; rivaroxaban; total hip arthroplasty; total knee arthroplasty; venous thromboembolism

Indexed keywords

ENOXAPARIN; RIVAROXABAN; ANTICOAGULANT AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL PATIENT; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; ADOLESCENT; CHEMICALLY INDUCED; COMPARATIVE STUDY; HIP REPLACEMENT; KNEE REPLACEMENT; MIDDLE AGED; PROCEDURES; PULMONARY EMBOLISM; VENOUS THROMBOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; ENOXAPARIN; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RIVAROXABAN; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84960415948     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028015626435     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. FastStats. http://www.cdc.gov/nchs/fastats/inpatient-surgery.htm. Accessed November 23, 2015.
2. J.HillT.Treasure; National Clinical Guideline Centre for Acute and Chronic Conditions. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ. 2010;340:c95. doi:10.1136/bmj.c95.
3. Y.Falck-YtterC.W.FrancisN.A.Johanson. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2, suppl):e278S-e325S. doi:10.1378/chest.11-2404.
4. S.RachidiE.S.AldinC.GreenbergB.SachsM.StreiffA.M.ZeidanThe use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery. Expert Rev Hematol. 2013;6:677-695.
5. M.A.MontJ.J.JacobsL.N.Boggio. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg. 2011;19:768-776.
6. D.WarwickJ.PerezC.VickeryG.BannisterDoes total hip arthroplasty predispose to chronic venous insufficiency?J Arthroplasty. 1996;11:529-533.
7. A.B.PedersenH.T.SorensenF.MehnertS.OvergaardS.P.JohnsenRisk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92:2156-2164.
8. W.H.GeertsD.BergqvistG.F.Pineo. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6, suppl):381S-453S.
9. B.I.ErikssonL.C.BorrisR.J.Friedman. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008;358:2765-2775.
10. A.K.KakkarB.BrennerO.E.Dahl. Extended duration rivaroxaban versus short term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet. 2008;372:31-39.
11. M.R.LassenW.AgenoL.C.Borris. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2009;358:2776-2786.
12. A.G.G.TurpieM.R.LassenB.L.Davidson. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee replacement arthroplasty: a randomized controlled trial. Lancet. 2009;373:1673-1680.
13. A.G.G.TurpieM.R.LassenB.I.Eriksson. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty: pooled analysis of four studies. Thromb Haemost. 2011;105:444-453. doi:10.1160/TH10-09-0601.
14. Xarelto [prescribing information].Titusville, NJ: Janssen Pharm Inc; 2014.
15. G.WasserlaufS.M.GrandiK.B.FilionM.J.EisenbergMeta-analysis of rivaroxaban and bleeding risk. Am J Cardiol. 2013;112:454-460. doi:10.1016/j.amjcard.2013.03.054.
16. R.C.WoodIIID.W.StewartL.Slusher. Retrospective evaluation of postoperative bleeding events in patients receiving rivaroxaban after undergoing total hip and total knee arthroplasty: comparison with clinical trial data. Pharmacotherapy. 2015;35:663-669.
17. Food and Drug Administration. Guidance for industry. Adverse reactions section of labeling for human prescription drug and biological products: content and format. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm075057. Accessed November 23, 2015.
18. J.L.CarsonB.J.GrossmanS.Kleinman. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157:49-58.
19. D.W.StewartJ.E.FreshourAspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence. Ann Pharmacother. 2013;47:63-74.
20. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355:1295-1302.
21. M.MonrealE.LafozJ.Roca. Platelet count, antiplatelet therapy and pulmonary embolism: a prospective study in patients with hip surgery. Thromb Haemost. 1995;73:380-385.
22. K.B.FreedmanK.R.BrookenthalR.H.FitzgeraldJrS.WilliamsJ.H.LonnerA meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000;82:929-938.